Advertisement

Neuroscience and Behavioral Physiology

, Volume 47, Issue 8, pp 890–894 | Cite as

The Role of Treatment Motivation Subsystems in the Overall Structure of Compliance in Patients Undergoing Psychopharmacotherapy

Article
  • 23 Downloads

Objective. To identify interactions in the structure of treatment motivation and compliance in patients in a psychiatric clinic. Materials and methods. A questionnaire and compliance scales were used to assess treatment motivation in 104 patients in the Department of Integrative Pharmaco- and Psychotherapy. These included 67 patients with schizophrenia and schizoaffective spectrum disorders, 15 with affective disorders, 13 with personality disorders and neurotic disorders, and nine with organic lesions. Results and conclusions. The key role in forming the overall level of treatment compliance is played by the motivation mechanism based on subjective experience of suffering from the disorder. Occurrence of amotivation syndrome has disastrous effects on the formation of compliance. Passive agreement by the patient to accept treatment leads to a degradation in the treatment alliance, which is worsened by cognitive deficit in patients and reduced insight into the condition. Predominance of external motivation to receive treatment, determined by the pressure of the patient’s immediate environment, also had adverse impact on the compliance subsystem linked with the surroundings. Pressure from relatives was often not transformed into adequate social support. Extremely low levels of internal motivation based on an understanding of the nature of the disorder, led to decreases in compliance associated with attitudes to treatment with medication.

Keywords

treatment motivation motivation in mental patients compliance on psychiatry structure of therapeutic motivation 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    M. Sajatovic, M. Davies, and D. Hrouda, “Enhancement of treatment adherence among patients with bipolar disorder,” Psychiatr. Serv., 55, No. 3, 264–269 (2004), doi:  https://doi.org/10.1176/appi.ps.55.3.264.CrossRefPubMedGoogle Scholar
  2. 2.
    C. Dolder, J. Lacro, S. Leckband, and D. Jeste, “Interventions to improve antipsychotic medication adherence: review of recent literature,” J. Clin. Psychopharmacol., 23, No. 4, 389–399 (2003), doi:  https://doi.org/10.1097/01.jcp.0000085413.08426.41.CrossRefPubMedGoogle Scholar
  3. 3.
    A. Zygmunt, M. Olfson, C. Boyer, and D. Mechanic, “Interventions to improve medication adherence in schizophrenia,” Am. J. Psyhiatry, 159, No. 10, 1653–1664 (2002), doi:  https://doi.org/10.1176/appi.ajp.159.10.1653.CrossRefGoogle Scholar
  4. 4.
    D. Barch, “The relationships among cognition, motivation, and emotion in schizophrenia: how much and how little we know,” Schizophr. Bull., 31, No. 4, 875–881 (2005), doi:  https://doi.org/10.1093/schbul/sbi040.CrossRefPubMedGoogle Scholar
  5. 5.
    D. Velligan, R. Kern, and J. Gold, “Cognitive rehabilitation for schizophrenia and the putative role of motivation and expectancies,” Schizophr. Bull., 32, No. 3, 474–485 (2005), doi:  https://doi.org/10.1093/schbul/sbj071.CrossRefGoogle Scholar
  6. 6.
    D. Gard, M. Fisher, C. Garrett, et al., “Motivation and its relationship to neurocognition, social cognition, and functional outcome in schizophrenia,” Schizophr. Res., 115, No. 1, 74–81 (2009), doi:  https://doi.org/10.1016/j.schres.2009.08.015.CrossRefPubMedPubMedCentralGoogle Scholar
  7. 7.
    E. Nakagami, B. Xie, M. Hoe, and J. Brekke, “Intrinsic motivation, neurocognition and psychosocial functioning in schizophrenia: Testing mediator and moderator effects,” Schizophr. Res., 105, No. 1–3, 95–104 (2008), doi:  https://doi.org/10.1016/j.schres.2008.06.015.CrossRefPubMedGoogle Scholar
  8. 8.
    V. D. Wied, Structure and Dynamics of the Process of Psychotherapy in Complex with Restorative Treatment of Low-Grade Schizophrenia: Auth. Abstr. Doct. Thesis in Med. Sci., Leningrad (1991).Google Scholar
  9. 9.
    G. V. Logvinovich, “Clinical characteristics of patients with episodes-progressive schizophrenia with the introverted type of adaptation,” in: Current Challenges in Psychiatry, Tomsk (1985).Google Scholar
  10. 10.
    F. Tremeau, J. Goldman, D. Antonius, and D. Javitt, “In-patients with schizophrenia report impaired situational motivation but intact global and social motivation,” Psychiatry Res., 210, No. 1, 43–49 (2013), doi:  https://doi.org/10.1016/j.psychres.2013.05.031.CrossRefPubMedGoogle Scholar
  11. 11.
    S. D. Mikhailova, “The challenge of nosophilic behavior in endogenousd patients with affective disorders,” in: Affective Disorders. Diagnosis, Treatment, Rehabilitation, Leningrad (1988), pp. 143–148.Google Scholar
  12. 12.
    V. N. Kalinkin, “The challenge of neohospitalization in occupational medicine workshops,” in: Current Challenges in Psychiatry, Tomsk (1983).Google Scholar
  13. 13.
    S. Goldstein and L. Dyche, “Family therapy of the schizophrenic poor,” in: Family Therapy in Schizophrenia, New York, London (1983), pp. 283–307.Google Scholar
  14. 14.
    J. Choi, K. H. Choi, L. Felice Reddy, and J. M. Fiszdon, “Measuring motivation in schizophrenia: Is a general state of motivation necessary for task-specific motivation?” Schizophr. Res., 153, No. 1–3, 209–213 (2014), doi:  https://doi.org/10.1016/j.schres.2014.01.027.CrossRefPubMedPubMedCentralGoogle Scholar
  15. 15.
    K. Choi, A. Saperstein, and A. Medalia, “The relationship of trait to state motivation: The role of self-competency beliefs,” Schizophr. Res., 139, No. 1–3, 73–77 (2012), doi:  https://doi.org/10.1016/j.schres.2012.05.001.CrossRefPubMedGoogle Scholar
  16. 16.
    W. Miller and G. Rose, “Toward a theory of motivational interviewing,” Am. Psychol., 64, No. 6, 527–537 (2009), doi:  https://doi.org/10.1037/a0016830.CrossRefPubMedPubMedCentralGoogle Scholar
  17. 17.
    N. Rusch and P. Corrigan, “Motivational interviewing to improve insight and treatment adherence in schizophrenia,” Psychiatr. Rehabil. J., 26, No. 1, 23–32 (2002), doi:  https://doi.org/10.2975/26.2002.23.32.CrossRefPubMedGoogle Scholar
  18. 18.
    T. Apodaca and R. Longabaugh, “Mechanisms of change in motivational interviewing: a review and preliminary evaluation of the evidence,” Addiction, 104, No. 5, 705–715 (2009), doi:  https://doi.org/10.1111/j.1360-0443.2009.02527.x.CrossRefPubMedPubMedCentralGoogle Scholar
  19. 19.
    R. Kemp and A. David, “Psychological predictors of insight and compliance in psychotic patients,” Brit. J. Psychiatry, 169, No. 4, 444–450 (1996), doi:  https://doi.org/10.1192/bjp.169.4.444.CrossRefGoogle Scholar
  20. 20.
    A. Swanson, M. Pantalon, and K. Cohen, “Motivational interviewing and treatment adherence among psychiatric and dually diagnosed patients,” J. Nerv. Ment. Dis., 187, No. 10, 630–635 (1999), doi:  https://doi.org/10.1097/00005053-199910000-00007.CrossRefPubMedGoogle Scholar
  21. 21.
    F. Chanut, T. G. Brown, and M. Donguier, “Motivational interviewing and clinical psychiatry,” Can. J. Psychiatry, 50, No. 11, 715–72 (2005).CrossRefPubMedGoogle Scholar
  22. 22.
    B. Lundahl, C. Kunz, C. Brownell, et al., “A meta-analysis of motivational interviewing: twenty-five years of empirical studies,” Res. Soc. Work Pract., 20, No. 2, 137–160 (2010), doi:  https://doi.org/10.1177/1049731509347850.CrossRefGoogle Scholar
  23. 23.
    J. C. Ferron, “Psychological mechanisms to treatment adherence among people with severe mental illness: validating treatment motivation and working alliance measures,” Dissert. Abstr. Int. A, Human. Soc. Sci., 68, No. 11, 486 (2008).Google Scholar
  24. 24.
    N. B. Lutova and M. Yu. Sorokin, “Characteristics of the treatment motivation of psychiatric clinic patients,” Vestn. Psikhoter., 51, 68–79 (2014).Google Scholar
  25. 25.
    N. B. Lutova, N. G. Neznanov, and V. D. Wied, “Compliance in psychiatry and means of assessing it,” Psikhoter. Psikhofarmakoter., No. 1, 8–1 (2008).Google Scholar
  26. 26.
    N. Lutova, N. Neznanov, and V. Wied, “The medication compliance in psychiatry and method of its assessment,” in: Yearbook of International Psychiatry and Behavioral Neurosciences, N. Barton (ed.), Nova Science Publ. Inc., New York (2009), pp. 399–408.Google Scholar

Copyright information

© Springer Science+Business Media, LLC 2017

Authors and Affiliations

  1. 1.Bekhterev St. Petersburg Research Psychoneurology InstituteSt. PetersburgRussia

Personalised recommendations